Tag Archives: Ablynx NV

Top Stories for Week of May 11, 2020

Quarrel flares up between White House and the CDC over reopening guidelines. The Centers for Disease Control and Prevention has repeatedly found its suggestions for fighting the coronavirus outbreak taking… Read more »

Europe, sans Basel, Copenhagen and Paris, taking on the US biotech titans.

The News: Since its birthday back in 1776, America has seen itself as the land of the new–and Europe as a landmass caught in the past. Nowhere is that truer… Read more »

Ablynx soars 60% on Novo’s latest hostile bid; grab a piece of this Belgian biotech because the real action’s just starting.

The News: Denmark’s Novo Nordisk A/S (Copenhagen), the world’s biggest insulin maker, went public Monday (January 8, 2018) with a €2.6-billion ($3.1 billion) bid for Belgian biotech group Ablynx NV… Read more »

From across the pond, 2017’s brightest European biotech stars; perhaps under US’s radar, but still ready to soar?

Many said good riddance to 2016 for biotech and pharma; things could only get better this year–and the European industry didn’t disappoint, says Labiotech.eu, the quintessential industry observer and news… Read more »